We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$618M
AUM Growth
+$153M
Cap. Flow
+$172M
Cap. Flow %
27.88%
Top 10 Hldgs %
4.55%
Holding
1,094
New
391
Increased
237
Reduced
151
Closed
315

Top Buys

Rank Stock Value
1
DAR icon
Darling Ingredients
DAR
+$3.15M
2
KEYS icon
Keysight
KEYS
+$3M
3
BDX icon
Becton Dickinson
BDX
+$2.85M
4
TREX icon
Trex
TREX
+$2.79M
5
KO icon
Coca-Cola
KO
+$2.74M

Top Sells

Rank Stock Value
1
PVH icon
PVH
PVH
+$2.16M
2
TWLO icon
Twilio
TWLO
+$2.16M
3
MPWR icon
Monolithic Power Systems
MPWR
+$2.16M
4
CB icon
Chubb
CB
+$2.15M
5
SPGI icon
S&P Global
SPGI
+$2.15M

Sector Composition

Rank Sector Weight
1 Industrials 18.44%
2 Technology 16.09%
3 Financials 12.33%
4 Healthcare 12.1%
5 Consumer Discretionary 11.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBP icon
26
Installed Building Products
IBP
$6.16B
$2.37M 0.38%
11,523
+7,719
+203% +$1.74M
TREX icon
27
Trex
TREX
$4.57B
$2.36M 0.38%
+31,857
New +$2.79M
HESM icon
28
Hess Midstream
HESM
$5.11B
$2.34M 0.38%
+64,268
New +$2.27M
MMS icon
29
Maximus
MMS
$3.2B
$2.33M 0.38%
27,238
+17,424
+178% +$1.46M
PPG icon
30
PPG Industries
PPG
$26.4B
$2.33M 0.38%
+18,515
New +$2.45M
ETN icon
31
Eaton
ETN
$155B
$2.32M 0.38%
+7,396
New +$2.39M
ITCI
32
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.31M 0.37%
+33,672
New +$2.34M
OVV icon
33
Ovintiv
OVV
$16.6B
$2.3M 0.37%
49,136
+23,503
+92% +$1.18M
SKT icon
34
Tanger
SKT
$4.8B
$2.3M 0.37%
+84,907
New +$2.34M
ROST icon
35
Ross Stores
ROST
$78.1B
$2.29M 0.37%
15,764
+1,228
+8% +$170K
MRK icon
36
Merck
MRK
$323B
$2.27M 0.37%
+18,344
New +$2.36M
SPOT icon
37
Spotify
SPOT
$102B
$2.27M 0.37%
7,222
+652
+10% +$196K
TRMB icon
38
Trimble
TRMB
$13B
$2.24M 0.36%
+40,077
New +$2.31M
MS icon
39
Morgan Stanley
MS
$337B
$2.21M 0.36%
+22,755
New +$2.17M
SKX
40
DELISTED
Skechers
SKX
$2.15M 0.35%
31,036
+26,430
+574% +$1.75M
BLK icon
41
Blackrock
BLK
$165B
$2.11M 0.34%
+2,682
New +$2.09M
UNH icon
42
UnitedHealth
UNH
$379B
$2.11M 0.34%
4,143
-220
-5% -$108K
TFX icon
43
Teleflex
TFX
$5.8B
$2.1M 0.34%
+9,983
New +$2.09M
APP icon
44
Applovin
APP
$139B
$2.08M 0.34%
+25,044
New +$1.94M
PG icon
45
Procter & Gamble
PG
$346B
$2.08M 0.34%
+12,620
New +$2.06M
GLNG icon
46
Golar LNG
GLNG
$4.99B
$2.08M 0.34%
66,317
-19,976
-23% -$528K
CE icon
47
Celanese
CE
$4.87B
$2.07M 0.34%
+15,354
New +$2.35M
CI icon
48
Cigna
CI
$77B
$2.06M 0.33%
+6,237
New +$2.15M
AMZN icon
49
Amazon
AMZN
$2.49T
$2.06M 0.33%
+10,636
New +$1.95M
PDCO
50
DELISTED
Patterson Companies, Inc.
PDCO
$2.04M 0.33%
84,431
+58,910
+231% +$1.47M
1
2
3 4 5

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q2 2024 Portfolio in Review

As of Q2 2024, Nebula Research & Development held 1,094 positions worth $618M, up 33% from $464M the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

Nebula Research & Development deployed $172M of net new capital in Q2 2024, opening 391 new positions and adding to 237 existing holdings. Its largest new stake was Darling Ingredients: 76,060 shares worth $2.8M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $2.12M trimmed.

  • Nebula Research & Development's largest Q2 2024 buy was Darling Ingredients: 76,060 shares worth $2.8M.
  • Nebula Research & Development added most to General Dynamics in Q2 2024, an estimated $2.57M increase.
  • Nebula Research & Development's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $2.12M.
  • Nebula Research & Development fully exited PVH in Q2 2024, selling an estimated $2.16M.
  • Nebula Research & Development's ten largest holdings make up 4.6% of its $618M portfolio in Q2 2024.
  • Nebula Research & Development opened 391 new positions and closed 315 in Q2 2024.
  • Nebula Research & Development's portfolio value rose 33% quarter-over-quarter to $618M.

Based on Nebula Research & Development's 13F filing for Q2 2024, filed 14 Aug 2024.